Union Health Ministry to amend New Drugs and Clinical Trials Rules for streamlining test licence, study applications

Sep 03, 2025

In accordance with the directions of Prime Minister Narendra Modi towards reducing the regulatory compliance and towards promoting ease of doing business in the...

Regulatory Grey Zone Sparks Controversy: Are India's New Drug Approval Rules Being Applied Unevenly?

Apr 09, 2026

Under the NDCT Rules, clinical trials in India may be waived only under specific conditions, primarily when a drug has already been approved and...

Regulatory Grey Zone Sparks Controversy: Are India's New Drug Approval Rules Being Applied Unevenly?

Apr 09, 2026

Under the NDCT Rules, clinical trials in India may be waived only under specific conditions, primarily when a drug has already been approved and...